(Q47566038)

English

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells

scientific article published on 13 December 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells (English)

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

object named as

Marina Caskey

14

0 references

Michel C. Nussenzweig

15

object named as

Michel C Nussenzweig

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

David C. Montefiori

13

object named as

David C Montefiori

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

author name string

Yehuda Z Cohen

1

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Julio C C Lorenzi

2

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Michael S Seaman

3

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Lilian Nogueira

4

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Till Schoofs

5

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Lisa Krassnig

6

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Allison Butler

7

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Katrina Millard

8

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Tomas Fitzsimons

9

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Xiaoju Daniell

10

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Juan P Dizon

11

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Irina Shimeliovich

12

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

language of work or name

0 references

publication date

13 December 2017

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Journal of Virology

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

92

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

5

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Early antibody therapy can induce long-lasting immunity to SHIV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

International network for comparison of HIV neutralization assays: the NeutNet report II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Broad neutralization coverage of HIV by multiple highly potent antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV sensitivity to neutralization is determined by target and virus producer cell properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

International network for comparison of HIV neutralization assays: the NeutNet report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

A method for identification of HIV gp140 binding memory B cells in human blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

High throughput functional analysis of HIV-1 env genes without cloning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

Predominant autoantibody production by early human B cell precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

22 May 2018

HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5809738

14 August 2018

Identifiers

10.1128/JVI.01883-17

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 March 2018

http://europepmc.org/abstract/PMC/5809738

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47566038&oldid=2159748258"